Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Biontech, Canbridge, Daiichi Sankyo, Esperion, Lumosa, Pfizer, Synairgen, Takeda.